Patient's question:
Morphological examination report: Thrombocytopenia, very active bone marrow hyperplasia, granular system 50.5%, red system 37%, granulocyte to red ratio 1.36:1; granular system fibrosis, proportions and morphology of all stages are generally normal; red system fibrosis, proportions slightly increasing based on mid and late-stage normoblasts, morphology normal; lymphocyte proportion relatively increased; a total of 124 megakaryocytes were observed in the entire smear, classified as 25, mature with platelets 0, mature without platelets 22, naked nuclei 1, immature without granules 2, platelets rarely seen. Opinion: Fibrosis of granulocytes, red cells, and megakaryocytes; megakaryocytes continuously increasing, poor platelet production, suggesting changes in bone marrow morphology associated with thrombocytopenia. What could have caused this condition, and what should be paid attention to?Doctor's answer:
Primary thrombocytopenic purpura is an immunological syndrome. The acute form often recurs after recovery from acute viral upper respiratory tract infections. In chronic cases, more than half of patients can be detected with antiplatelet antibodies in the serum. Factors such as cellular immune function deficiencies, splenic factors, and higher estrogen levels can all lead to thrombocytopenia. The acute form is usually self-limiting, with more than 80% resolving spontaneously, with an average course of 4–6 weeks. In very rare cases, it may develop into or evolve into chronic thrombocytopenia over several years. Medications such as inosine, amino acid peptides, and nucleotides can be used to raise platelet counts. For skin bleeding, hemostatic drugs are applied. Additionally, corticosteroids, immunosuppressants, and immunoglobulins are used for treatment. If necessary, splenectomy may be performed.